Yarrow Bioscience Inc.

Last updated September 27, 2026

Favorite this organization

Organization details

Legal name: Yarrow Bioscience Inc.
Former names: VYNE Therapeutics Inc. Menlo Therapeutics Inc. Tigercat Pharma, Inc.
Ownership: Public
Status: Active
Sector (GICS): Health Care
SIC code: 2834 — Pharmaceutical Preparations
Jurisdiction of incorporation: Delaware
Headquarters city: New Haven
Headquarters state / province: Connecticut
Headquarters country: United States
Fiscal year end: December
Ticker symbol: YARW
Primary stock exchange: Nasdaq

Identifiers

SEC CIK: 0001566044
EIN: 45-3757789

Board of directors

Follow this board

Anthony D. Bruno · Director
Since 2023
Christine Borowski · Director
Since 2023
David Domzalski · Director · PRESIDENT AND CEO
Since 2023
Elisabeth Sandoval · Director
Since 2023
Mona Ashiya · Director
Since 2026
Patrick G. Lepore · Director
Since 2023
Peter B. Silverman · Director
Since 2026
Rebecca Frey · Director · Chief Executive Officer
Since 2026
Sharon Barbari · Director
Since 2023
Steven L. Basta · Director
Since 2023
Steven L. Hoerter · Director
Since 2026
Sven Ante Lundberg · Director
Since 2026
Tyler Zeronda · Director
Since 2026
William Richard White · Director
Since 2026

Chief executives

Rebecca Frey · Chief Executive Officer

Since July 2026

David Domzalski · President and CEO

Until July 2026 · Former

Director election results

Annual meeting of December 12, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Steven L. Basta

73.6%

Board connections

7 of this board's directors also sit on 10 other boards. 10 are in the same sector.

Shared director Other board Same sector

Disc Medicine Inc. Same sector
via Mona Ashiya and William Richard White
C4 Therapeutics Inc. Same sector
via Steven L. Hoerter
LeonaBio Inc. Same sector
via Peter B. Silverman
MBX Biosciences Inc. Same sector
via Steven L. Hoerter
Oric Pharmaceuticals Inc. Same sector
via Steven L. Hoerter
PROCEPT BioRobotics Corporation Same sector
via Elisabeth Sandoval
Phathom Pharmaceuticals Inc. Same sector
via Steven L. Basta
Q32 Bio Inc. Same sector
via Sven Ante Lundberg
Shattuck Labs Inc. Same sector
via Mona Ashiya
Vor Biopharma Inc. Same sector
via Sven Ante Lundberg

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months: $0; 0 purchases by 0 insiders
Sold, last 12 months: $0; 0 sales by 0 insiders

Date	Insider	Transaction	Shares	Price	Value
Jul 29, 2026	Roderick Wong 10% owner	Other	−133,290	—	—
Jul 23, 2026	David Domzalski Director, Officer (PRESIDENT AND CEO)	Shares withheld for tax	−79,391	$0.90	$71,452
Jul 23, 2026	Harsch Mutya Officer (CHIEF LEGAL OFFICER AND GC)	Shares withheld for tax	−22,516	$0.90	$20,264
Jul 23, 2026	Stuart Iain Officer (CHIEF SCIENTIFIC OFFICER)	Shares withheld for tax	−15,405	$0.90	$13,865
Jul 23, 2026	Tyler Zeronda Officer (CHIEF FINANCIAL OFFICER)	Shares withheld for tax	−22,516	$0.90	$20,264
Jun 30, 2026	David Domzalski Director, Officer (PRESIDENT AND CEO)	Shares withheld for tax	−12,214	$0.65	$7,939
Jun 30, 2026	Harsch Mutya Officer (CHIEF LEGAL OFFICER AND GC)	Shares withheld for tax	−3,464	$0.65	$2,252
Jun 30, 2026	Stuart Iain Officer (CHIEF SCIENTIFIC OFFICER)	Shares withheld for tax	−2,370	$0.65	$1,541
Jun 30, 2026	Tyler Zeronda Officer (CHIEF FINANCIAL OFFICER)	Shares withheld for tax	−3,464	$0.65	$2,252
May 29, 2026	David Domzalski Director, Officer (PRESIDENT AND CEO)	Grant or award	+30,791	$0.31	$9,545
Mar 31, 2026	Zeronda Tyler Officer (CHIEF FINANCIAL OFFICER)	Shares withheld for tax	−4,007	$0.60	$2,404
Mar 31, 2026	Stuart Iain Officer (CHIEF SCIENTIFIC OFFICER)	Shares withheld for tax	−2,876	$0.60	$1,726
Mar 31, 2026	Harsch Mutya Officer (CHIEF LEGAL OFFICER AND GC)	Shares withheld for tax	−4,007	$0.60	$2,404
Mar 31, 2026	David Domzalski Director, Officer (PRESIDENT AND CEO)	Shares withheld for tax	−14,232	$0.60	$8,539
Dec 31, 2025	David Domzalski Director, Officer (PRESIDENT AND CEO)	Shares withheld for tax	−12,684	$0.58	$7,357

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

3M Company NYSE: MMM · ST Paul, United States Organization ABVC BioPharma Inc. Nasdaq: ABVC · Fremont, United States Organization ACADIA Pharmaceuticals Inc. Nasdaq: ACAD · SAN Diego, United States Organization ADMA Biologics Inc Nasdaq: ADMA · Ramsey, United States Organization

Questions about Yarrow Bioscience Inc.

Who is the CEO of Yarrow Bioscience Inc.?

Rebecca Frey has been Yarrow Bioscience Inc.'s Chief Executive Officer since July 2026.

How many directors are on Yarrow Bioscience Inc.'s board?

Yarrow Bioscience Inc.'s board has 14 directors: Anthony D. Bruno, Christine Borowski, David Domzalski, Elisabeth Sandoval, Mona Ashiya, Patrick G. Lepore, Peter B. Silverman, Rebecca Frey, Sharon Barbari, Steven L. Basta and 4 others.

How is Yarrow Bioscience Inc. connected to…? → Spot something wrong? Report a correction

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="yarrow-bioscience-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

No reviews yet. Be the first to write one.